Not applicableLooking for participantsNCT00697411What this trial is testingStudy of Selected X-Linked Disorders: Aicardi SyndromeWho this might be right forAicardi SyndromeBrain Disorders Baylor College of Medicine 500
Large-scale testing (Phase 3)Ended earlyNCT04517253What this trial is testingBaricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGSWho this might be right forNakajo-Nishimura SyndromeChronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature SyndromeSTING-Associated Vasculopathy With Onset in Infancy+1 more Eli Lilly and Company 10
Not applicableApproved For MarketingNCT01724580What this trial is testingCompassionate Use Protocol for the Treatment of Autoinflammatory SyndromesWho this might be right forChronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE)Juvenile Dermatomyositis (JDM)Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)+1 more Eli Lilly and Company
Not applicableLooking for participantsNCT03047369What this trial is testingThe Myelin Disorders Biorepository ProjectWho this might be right forLeukodystrophyWhite Matter DiseaseLeukoencephalopathies+63 more Children's Hospital of Philadelphia 12,000
Not applicableStudy completedNCT02699190What this trial is testingLeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for LeukodystrophiesWho this might be right forLeukodystrophyWhite Matter Disease4H Syndrome+61 more Children's Hospital of Philadelphia 236
Not applicableStudy completedNCT06898372What this trial is testingEvaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières SyndromeWho this might be right forAicardi-Goutières Syndrome (AGS) IRCCS Fondazione Stella Maris 24
Testing effectiveness (Phase 2)Study completedNCT04731103What this trial is testingInhibition of Reverse Transcription in Aicardi-Goutières SyndromeWho this might be right forAicardi-Goutières Syndrome University of Edinburgh 13
Testing effectiveness (Phase 2)Study completedNCT02363452What this trial is testingReverse Transcriptase Inhibitors in AGSWho this might be right forAicardi-Goutières Syndrome (AGS) Assistance Publique - Hôpitaux de Paris 11
Testing effectiveness (Phase 2)Study completedNCT03921554What this trial is testingJAK Inhibitor Treatment in AGSWho this might be right forAicardi Goutieres Syndrome Adeline Vanderver, MD 54
Testing effectiveness (Phase 2)WithdrawnNCT03304717What this trial is testingReverse Transcriptase Inhibitors in Aicardi Goutières SyndromeWho this might be right forAicardi Goutières Syndrome Children's Hospital of Philadelphia
Not applicableStudy completedNCT03094793What this trial is testingImpact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the EpilepsiesWho this might be right forEpilepsy University Hospital, Grenoble 162
Testing effectiveness (Phase 2)Ended earlyNCT05613868What this trial is testingTPN-101 in Aicardi-Goutières Syndrome (AGS)Who this might be right forAicardi-Goutières Syndrome (AGS) Transposon Therapeutics, Inc. 4
Not applicableUnknownNCT00305305What this trial is testingBrain Development Research ProgramWho this might be right forBrain DisordersAicardi Syndrome University of California, San Francisco 2,000